|
|
|
Volumn 28, Issue 6, 1996, Pages 3210-3211
|
|
Influence of the anti-CD25 monoclonal antibody BT563 on clinical and biological rejection after orthotopic liver transplantation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
INOLIMOMAB;
INTERLEUKIN 2;
INTERLEUKIN 2 RECEPTOR;
MESSENGER RNA;
METHYLPREDNISOLONE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
GENE EXPRESSION;
GRAFT REJECTION;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER TRANSPLANTATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ANTIBODIES, MONOCLONAL;
AZATHIOPRINE;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INTERLEUKIN-2;
LIVER TRANSPLANTATION;
METHYLPREDNISOLONE;
PILOT PROJECTS;
RECEPTORS, INTERLEUKIN-2;
TRANSCRIPTION, GENETIC;
|
|
EID: 0029809536
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (0)
|
